Minimally invasive surgery has become an increasingly popular option in the treatment of cardiovascular disease. The risk and recovery time from traditional open heart surgery are reduced by performing catheter-based surgery. A guide wire and catheter is inserted into the femoral artery advanced through the vascular system to the site of disease. Surgical tools such as angioplasty balloons can be deployed at the end of these catheters. Guidant Corporation has become a world leader in the field of cardiovascular medical devices for catheter-based surgery. But the development of the next generation of devices depends on how well the designers at Guidant can test and evaluate their products. Currently available test methods, including animal models and simple plastic models, have significant limitations. Neither model accurately simulates the human disease state or true in vivo conditions.
In recent years, Guidant has developed a
Synthetic Arterial Model (SAM) for product development and physician training
in their
Figure 1: (Top) Synthetic Arterial Model integrated into
phantom body
(Bottom) SAM aorta
Figure 2: SAM heart under fluoroscope with contrast injected into coronary arteries
The Guidant SAM has many advantages over alternative pre-clinical models. However, the SAM lacks several necessary features to replicate in vivo conditions in human patients. These features include pulsatile flow through the arteries at physiologic pressure, a beating heart and respiratory motion. The incorporation of these features into the Guidant SAM would greatly improve the ability of Guidant engineers to evaluate their designs under surgical conditions. The improved clinical realism of the SAM would also increase physician comfort with the model and more importantly, Guidant medical devices.